Naegis is attending ARVO 2024   May 5th 9th  |  Seattle

Our Partners

Naegis is pleased to partner with Ora Inc., the world’s leading ophthalmic research organization, for the development of its lead compound for allergic eye diseases.

Partnering: The Opportunities Beyond Eye Disease

Leukotrienes are known to have a role in many other inflammatory disease such as serious lung disease, cardiovascular disease and cancer, among others. Our core focus at this time is on ophthalmology. To access the broader opportunities for our proprietary compound library and multiple potential lead candidates, we are open to talking with companies who are interested in working with us to accelerate programs towards new treatments for other inflammatory diseases.

Interested in a Partnership?

If  your organization is interested in exploring partnerships with Naegis, please contact us at:

Naegis Pharmaceuticals Inc.
Suite 720, 999 West Broadway
Vancouver, BC V5Z 1K5
Phone: (604) 235-1682